Skip to content
★ Sign in to follow
BV

Brad Vale

Board Director
Director
Nevro Corp
Total declarations
16
Company
1
▲ Purchases (1 ops.)
€94k
▼ Sales (4 ops.)
€736k

Latest filing published 26 May 2021 for NEVRO CORP.

Filing timeline

BuySale
Brad Vale

Insider track record

Disclosed buys
1
Disclosed sells
4
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Brad Vale: trading record in brief

Brad Vale is a declared insider of Nevro Corp (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 13 November 2015 to 25 May 2021, the count stands at 16 filings.

The open-market side counts 1 purchase for €94k alongside 4 sales for €736k. On balance, insiders were net sellers of €642k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 11 share grants. In 2021 alone, the filings show no purchases and 4 sales.

Most recently, on 26 May 2021, the filings show a share grant in Nevro Corp. The clock since the last published purchase (16 November 2015) now reads 4,011 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Brad Vale

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    1,167 shares0Common StockSEC:0001567619-21-011224:0
  • ▼
    DirectorExecutivesNevro Corp
    83,523 USD24SEC
    503 shares@ US$166.059.4% of flowCommon StockSEC:0001567619-21-005535:0
  • ▼
    DirectorExecutivesNevro Corp
    336,084 USD27SEC
    2,012 shares@ US$167.0437.8% of flowCommon StockSEC:0001567619-21-005535:1
  • ▼
    DirectorExecutivesNevro Corp
    215,113 USD25SEC
    1,278 shares@ US$168.3224.2% of flowCommon StockSEC:0001567619-21-005535:2
  • ▼
    DirectorExecutivesNevro Corp
    255,311 USD26SEC
    1,510 shares@ US$169.0828.7% of flowCommon StockSEC:0001567619-21-005535:3
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    90 shares0Common StockSEC:0001567619-21-000322:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    113 shares0Common StockSEC:0001567619-20-017491:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    65 shares0Common StockSEC:0001567619-20-012890:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    1,376 shares0Common StockSEC:0001567619-20-011149:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    157 shares0Common StockSEC:0001567619-20-007442:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    134 shares0Common StockSEC:0001567619-20-000331:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    183 shares0Common StockSEC:0001567619-19-019159:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    2,913 shares0Common StockSEC:0001567619-19-011872:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    3,785 shares0Common StockSEC:0001140361-18-025424:0
  • ◆
    DirectorExecutivesNevro Corp
    0SEC
    1,518 shares0Common StockSEC:0001140361-17-022925:0
  • ▲
    DirectorExecutivesNevro Corp
    101,520 USD0SEC
    2,000 shares@ US$50.76Common StockSEC:0001140361-15-041886:0
    Canonical exit: 11 Feb 2016 (T+90)

16 of 16 declarations